InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today released the following statement. Recently, H.R. 5371, the ‘Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and…
The Bank of Canada Governing Council met on Wednesday (December 10) for the final rate-setting meeting of 2025 and…
Rio Silver Inc. (the ‘Company’ or ‘Rio Silver’) (TSX.V: RYO,OTC:RYOOF) (OTC: RYOOF) announces that, following regulatory approval, the closing…
(TheNewswire) Vancouver, Canada, December 12, 2025 TheNewswire – Spartan Metals Corp. (‘ Spartan ‘ or the ‘ Company ‘)…
This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. Disclosure: This does not…
KEY HIGHLIGHTS: MIE has successfully completed testing, confirming suitability of Santa Maria Eterna silica sand for high quality, antimony-free…
Bold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce the closing of a non-brokered private placement…